CWM
AXSM icon

CIBC World Markets’s Axsome Therapeutics AXSM Stock Holding History

CIBC World Markets’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$496K Buy
+2,715
New +$379K ﹤0.01% 833
2025
Q2 		$521K Sell
4,987
-3,183
-39% -$337K ﹤0.01% 851
2025
Q1 		$953K Buy
8,170
+4,725
+137% +$538K 0.01% 709
2024
Q4 		$291K Buy
+3,445
New +$317K ﹤0.01% 947

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Markets's AXSM Position: Q4 2025 in Review

CIBC World Markets opened a new position in Axsome Therapeutics (AXSM) in Q4 2025: 2,715 shares worth $496K. The stake represents ﹤0.01% of the portfolio and ranks #833 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in AXSM as recently as Q2 2025.

CIBC World Markets first reported a position in AXSM in Q4 2024 and has held it in 4 quarters since. The position peaked at $953K in Q1 2025. 398 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

  • CIBC World Markets held 2,715 shares of Axsome Therapeutics worth $496K as of Q4 2025.
  • Axsome Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Axsome Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #833 holding.
  • CIBC World Markets first reported a position in Axsome Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Axsome Therapeutics position peaked at $953K in Q1 2025.
  • 398 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.